NCT00634309View on ClinicalTrials.gov

Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)

PHASE3CompletedINTERVENTIONAL
Enrollment

597

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Congestive Heart Failure
Interventions
DRUG

Candesartan

DRUG

Placebo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY